Newsroom | 18112 results
Sorted by: Latest
-
Bial Launches Education and Awareness Campaign for World Parkinson’s Day
PORTO, Portugal--(BUSINESS WIRE)--To mark World Parkinson’s Day, Bial today launches “Dialogues with Parkinson’s”....
-
Prime Healthcare Services, Inc. Schedules 2026 1st Quarter Earnings Conference Call
ONTARIO, Calif.--(BUSINESS WIRE)--Prime Healthcare Services will report earnings the morning of May 12th, 2026, to be followed by a conference call at 2:00 p.m. (ET) to discuss the reported results. To pre-register prior to the call, email EGarcia27@primehealthcare.com to facilitate attaining your individual pin that will allow direct access to the call. About Prime Healthcare and Prime Healthcare Foundation Prime Healthcare is an award-winning health system operating 54 hospitals and more than...
-
New Billboards Tout AHF as Top HIV Provider, Promote STD Testing
LOS ANGELES--(BUSINESS WIRE)--New Billboards Tout AHF as Top HIV Provider, Promote STD Testing...
-
Emalex Receives U.S. Patent for Orally Disintegrating Ecopipam Formulation
CHICAGO--(BUSINESS WIRE)--Emalex Biosciences received a patent covering an orally disintegrating tablet (ODT) formulation of ecopipam, an investigational D1 antagonist...
-
athenahealth Partners with rater8 to Add AI-Powered Reputation Management to Industry-leading AI-native athenaOne® Solution
BOSTON--(BUSINESS WIRE)--athenahealth today announced it is bringing rater8’s AI-powered reputation management capabilities into AI-native athenaOne. The integration embeds rater8’s healthcare-focused review, listings, and patient feedback tools into athenaOne workflows — enabling practices to request and respond to reviews, maintain listings, monitor sentiment, and act on insights without leaving athenaOne. As generative AI reshapes how patients discover and evaluate providers, reviews and lis...
-
The Difference Card Appoints Heather Crovo as Vice President of Human Resources
GREENWICH, Conn.--(BUSINESS WIRE)--The Difference Card, a leader in innovative healthcare cost containment solutions, announced the appointment of Heather Crovo to its Executive Team as Vice President of Human Resources, strengthening the company’s leadership bench at a pivotal time of rapid growth and expansion. As The Difference Card continues to experience tremendous hiring momentum across departments, the addition of a seasoned HR Executive underscores the organization’s commitment to scali...
-
Ravin Consultants Announces Next Chapter of Leadership
BRADENTON, Fla.--(BUSINESS WIRE)--Ravin Consultants names Dr. Robert Ferraro CEO as Founder Jennifer Lockwood becomes Executive Chair, supporting growth in a complex 340B landscape....
-
Coya Therapeutics Announces Publication Demonstrating Correlation Between Longitudinal Biomarker Data and Clinical Outcomes Supporting the Mechanistic Rationale for COYA 302 in Patients with ALS
HOUSTON--(BUSINESS WIRE)--Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance Treg function, announces the publication of a research study led by Dr. David Beers and Dr. Stanley Appel at the Houston Methodist Neurological Institute. The study included the longitudinal measurement of well-characterized serum biomarkers of lipid peroxidation (4-hydroxy-2-nonenal [4-HNE]), systemic inflammation (lipopolys...
-
CMS Grants Fresenius Kabi COVID-19 Indication-Specific HCPCS Codes for Tyenne® (tocilizumab-aazg)
LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, a part of Fresenius, and a leading provider of essential medicines and medical technologies, announced today that the Centers for Medicare & Medicaid Services has issued indication-specific Healthcare Common Procedure Coding System (HCPCS) codes for Tyenne® (tocilizumab-aazg) for the treatment of COVID-19. The new codes will be effective for Medicare claims for eligible patients administered Tyenne on April 1, 2026. These new COVID-19 HCPC...
-
Amazon Pharmacy to Offer Eli Lilly and Company’s New GLP-1 Pill Foundayo via Same-Day Delivery
SEATTLE--(BUSINESS WIRE)--Amazon Pharmacy (NASDAQ: AMZN), a full-service digital pharmacy that offers fast medication delivery directly to customers' homes, now offers Eli Lilly and Company’s recently approved GLP-1 medication, Foundayo™, a once daily oral treatment for adults with obesity or overweight with weight-related medical problems. Customers with a valid prescription can order Foundayo through Amazon Pharmacy, see real-time medication availability and transparent pricing, and receive f...